Devices › Device types
FDA product code MJP · class 3 · Ophthalmic
Lens, intraocular, toric optics: medical device reports filed with FDA
8,214 reports carry this product code, 2008–2026; 18 brands with a page.
- 8,214
- reports with this product code
- 0% of all MAUDE reports
- 1,757
- reports, 12 months to August 2026
- 1,673 in the 12 months before
- 42%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code MJP is FDA's classification for "Lens, intraocular, toric optics" (ophthalmic panel), a class 3 device. 8,214 medical device reports carry this product code, 0% of the MAUDE database, from February 2008 to August 2026.
1,757 reports arrived in the 12 months to August 2026, close to the 1,673 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.5%), malfunction (42%) and other (3.5%). 18 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| AcrySof IQ Toric Singlepiece IOL | 1,743 | 60 | 0% | 30.8% |
| Tecnis Iol | 1,159 | 715 | 0% | 42.9% |
| Clareon Toric Aspheric Hydrophobic Acrylic IOL with AutonoME Delivery System | 566 | 235 | 0% | 94.4% |
| Clareon Toric IOL | 566 | 207 | 0% | 69.5% |
| Clareon PanOptix Toric Trifocal UV Absorbing IOL | 488 | 75 | 0% | 18% |
| Clareon PanOptix Toric Trifocal Hydrophobic IOL | 430 | 136 | 0% | 45.3% |
| Clareon Vivity Toric Extended Vision UV Absorbing IOL | 388 | 95 | 0% | 23.5% |
| Clareon Vivity Toric Extended Vision Hydrophobic IOL | 314 | 119 | 0% | 48.4% |
| Clareon Toric UV Absorbing IOL | 309 | 126 | 0% | 54% |
| Acrysof Restor Toric Singlepiece Iol | 269 | 0 | 0% | 26% |
| Acrysof Iq Toric | 258 | 0 | 0% | 9.1% |
| Acrysof Toric | 251 | 0 | 0% | 18.2% |
| Trulign Toric Posterior Chamber Iol | 179 | 0 | 0% | 0.6% |
| CLAREON PANOPTIX PRO Trifocal TORIC UV Absorbing IOL w/AutonoME Delivery System | 150 | 146 | 0% | 42.7% |
| Tecnis | 26 | 0 | 0.1% | 18.1% |
| Tecnis Symfony Toric | 4 | 0 | 0% | 7.3% |
| Clareon Vivity Extended Vision Hydrophobic IOL | 1 | 92 | 0% | 51.2% |
| Crystalens Intraocular Lens | 1 | 0 | 0% | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Alcon Research - Huntington | 3,074 | 37.4% |
| Alcon Laboratories Ireland | 2,782 | 33.9% |
| Amo Puerto Rico Mfg | 1,300 | 15.8% |
| Bausch + Lomb | 327 | 4% |
| Alcon Research / Huntington | 324 | 3.9% |
| Alcon Research /Huntington | 147 | 1.8% |
| Amo Manufacturing Netherlands | 84 | 1% |
| Bausch & Lomb | 53 | 0.6% |
| Johnson & Johnson Surgical Vision | 16 | 0.2% |
| Abbott Medical Optics | 14 | 0.2% |
| Alcon Laboratories | 5 | 0.1% |
| Staar Surgical | 5 | 0.1% |
| Abbott | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 725 | 8.8% |
| Scratched material | 644 | 7.8% |
| Device dislodged or dislocated | 485 | 5.9% |
| Insufficient device problem information | 374 | 4.6% |
| Material discolored | 275 | 3.3% |
| Device remains implanted | 260 | 3.2% |
| Device difficult to setup or prepare | 234 | 2.8% |
| Defective devicethe device was defective | 216 | 2.6% |
| Failure to deliverthe device did not deliver the dose or item | 202 | 2.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 196 | 2.4% |
| Material split, cut or torn | 180 | 2.2% |
| Crackthe device cracked | 170 | 2.1% |
| Malposition of device | 168 | 2% |
| Material twisted/bent | 165 | 2% |
| Unstable | 130 | 1.6% |
| Failure to advance | 121 | 1.5% |
| Product quality problem | 104 | 1.3% |
| Device damaged by another device | 86 | 1% |
| Material opacification | 77 | 0.9% |
| Inaccurate delivery | 76 | 0.9% |
Questions about lens, intraocular, toric optics reports
What is product code MJP?
FDA's classification code for "Lens, intraocular, toric optics", class 3, reviewed by the ophthalmic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
8,214 reports through August 2026, 1,757 of them in the latest 12 months.
Which brands appear most often?
AcrySof IQ Toric Singlepiece IOL (1,743), Tecnis Iol (1,159), Clareon Toric Aspheric Hydrophobic Acrylic IOL with AutonoME Delivery System (566), Clareon Toric IOL (566) and Clareon PanOptix Toric Trifocal UV Absorbing IOL (488). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.